US Patent No: 4,711,902
Number of patents in Portfolio can not be more than 2000
Medicament formulation
Stats
-
Dec 8, 1987
Issued date -
Oct 18, 1984
filing date -
06/662,469
serial no -
Expired
status
Importance
Loading Importance Indicators...
Abstract
A medicament formulation of intravenous injection comprising a medicinally active compound, a lipid phase, an emulsifier and water, the lipid phase being present in up to about 30% by weight, the emulsifier being present in about 0.1 to 10% by weight, and water being present up to 100%, the lipid phase containing up to about 50% by weight of a sparingly soluble medicinally active compound, and consisting essentially of (a) at least one ester principally of at least one medium chain-length fatty acid, or (b) a mixture of at least one ester principally of at least one medium chain-length fatty acid with at least one vegetable or animal oil, the mixture containing at least 10% by weight of the ester principally of the medium chain-length fatty acid, or (c) at least one ester principally of at least one medium chain-length fatty acid, at least one vegetable or animal oil, or a mixture thereof, in combination with 0.3 to 200% by weight of benzyl alcohol based on the content of lipid or oil. A greater amount of medicinal agent can be administered in a reduced total volume of injectable liquid.
Loading the Abstract Image...
First Claim
Related Publications
Loading Related Publications...
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art
| Patent Info | (Count) | # Cites | Year |
|---|---|---|---|
|
|
|||
| 4,264,611 2,6-Dimethyl-4-2,3-disubstituted phenyl-1,4-dihydro-pyridine-3,5-dicarboxylic acid-3,5-asymmetric diesters having hypotensive properties, as well as method for treating hypertensive conditions and pharmaceutical preparations containing same | 22 | 1979 | |
|
|
|||
| 4,237,137 Sila-substituted 1,4-dihydropyridine derivatives and their medicinal use | 10 | 1979 | |